On an ingredient list it appears as potassium azeloyl diglycinate. In marketing copy it is usually called glycinated azelaic acid. It is one of those ingredients people either skip past entirely or assume is a watered-down substitute for the real thing.
Neither is quite right. Here is what it actually is.
What It Is
Potassium azeloyl diglycinate is azelaic acid that has been chemically bonded to two glycine molecules and formed into a potassium salt.
The purpose of that modification is solubility. Azelaic acid itself dissolves poorly in water, which is the reason it has traditionally been formulated as a thick suspension of solid particles. Attaching glycine and forming a salt produces a compound that dissolves readily in water.
That single property is why it exists. It allows azelaic acid chemistry to be delivered in a clear, water-based product rather than an opaque cream.
How It Differs From Azelaic Acid
Think of it as a related compound rather than the same molecule in a different wrapper.
Solubility. This is the main difference. Azelaic acid is poorly water soluble. Potassium azeloyl diglycinate is freely water soluble.
Feel. Because it dissolves, it does not contribute grit or require a thick base.
Humectancy. The glycine portion gives it mild water-binding properties, which azelaic acid alone does not have.
Evidence base. This is the important distinction and the one usually glossed over. The large body of clinical evidence for acne, rosacea and melasma was generated using azelaic acid at 15% and 20%, not using potassium azeloyl diglycinate. Data specific to the derivative is considerably thinner.
What the Research Shows
Published evidence on potassium azeloyl diglycinate is limited, and most of what exists tests it inside multi-ingredient formulas rather than on its own.
The clearest example is a randomized, double-blind, controlled trial in 67 Thai adults with mild to moderate melasma. Participants applied an emulsion containing tranexamic acid, potassium azeloyl diglycinate and niacinamide twice daily for eight weeks, alongside SPF 30. The treated group showed a statistically significant reduction in relative melanin value compared with control by week 6. Adverse events were comparable between groups, at 12% and 15%.
That is a genuine randomized trial with a positive result. It is also a three-active formula, so it cannot tell you what potassium azeloyl diglycinate contributed on its own.
The honest position is that the rationale is sound, there is some supportive clinical data in combination products, and there is nothing approaching the volume or quality of evidence that exists for azelaic acid at prescription strength.
Because published data on the derivative is limited, look for brands that have tested their finished formula in a third-party clinical study. Remedy's 15% Azelaic Acid Complex Advanced Clarifying Serum (10% pure azelaic acid + 5% glycinated azelaic acid), for example, was clinically proven to improve dark spots and redness in 97.5% of participants in a single-center, dermatologist-evaluated clinical study (n=40).
Why It Appears Alongside Azelaic Acid
Increasingly you will see both on the same ingredient list rather than one or the other.
The logic is that they solve different problems. Azelaic acid carries the clinical evidence. Its derivative carries the water solubility. Using both allows a formulator to include a meaningful amount of well-studied azelaic acid while also delivering azelaic chemistry through a water-soluble route.
When you see a product described as a complex with two figures, such as 10% azelaic acid plus 5% glycinated azelaic acid, that is what is being described: two related compounds, not one number split in two.
It is worth reading those numbers carefully. A product containing 15% of the derivative and none of the parent compound is not equivalent to one containing 15% azelaic acid, even though both might be summarized as 15% on the front of the box.
Is It a Weaker Version?
Not exactly, and the framing is unhelpful.
It is a different compound with different properties. It is more water soluble, milder in feel, and mildly hydrating. It also has far less direct clinical evidence behind it.
Calling it weaker implies a known potency ratio that has not been established. Calling it equivalent implies an evidence base that does not exist. The accurate description is that it is a solubility solution with a supportive but limited evidence base, most useful as part of a formula rather than as a straight substitute for azelaic acid.
How to Use It
It behaves like any water-soluble active. Apply to clean, dry skin, before heavier products. It does not increase photosensitivity, and it can be used morning or evening.
It is generally well tolerated, including on sensitive skin, which is one reason it appears in gentler formulations.
As with any ingredient acting on pigment, daily sunscreen is essential and results are assessed over 8 to 12 weeks rather than weeks.
Mistakes to Avoid
🚫 Reading it as interchangeable with azelaic acid:
Different compound, different evidence base.
🚫 Adding percentages without reading what they are attached to:
A combined figure can describe two different compounds.
🚫 Dismissing it as filler:
It solves a real formulation problem and has some supportive trial data.
🚫 Reading the derivative as a stand-in for the clinical evidence:
The trial data sits with azelaic acid itself, which is why the derivative is most useful alongside it rather than in place of it.
Who Should Be Cautious
Generally well tolerated across skin types, with a low reported rate of irritation. As with any new active, introduce it on its own rather than alongside another new product, so you can identify the source if you react.
Final Thoughts
Potassium azeloyl diglycinate is a sensible piece of formulation chemistry that gets described in two equally wrong ways: as a marketing substitute for azelaic acid, or as an equal alternative to it. It is neither. It is a water-soluble relative that makes lighter textures possible, with a modest evidence base of its own, and it is at its most useful sitting alongside azelaic acid rather than replacing it.
